Jonathan E Campbell Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

1/2023	100 years of glucagon and 100 more.
11/2022	The past, present, and future physiology and pharmacology of glucagon.
6/2015	Islet α cells and glucagon--critical regulators of energy homeostasis.
12/2006	Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan E Campbell Research Topics

Disease

15	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2013
14	Body Weight (Weight, Body) 01/2023 - 09/2012
13	Obesity 12/2022 - 01/2012
11	Insulin Resistance 01/2022 - 05/2006
6	Hyperglycemia 01/2020 - 03/2007
5	Weight Loss (Weight Reduction) 01/2023 - 12/2022
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 12/2006
4	Inflammation (Inflammations) 01/2021 - 03/2016
4	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 12/2006
3	Weight Gain 01/2022 - 01/2020
2	Glucose Intolerance 10/2020 - 04/2017
2	Myocardial Infarction 01/2018 - 08/2014
2	Diabetes Mellitus 06/2015 - 03/2007
1	Fatty Liver 01/2023
1	Insulinoma 01/2021
1	Succinyl-CoA:3-oxoacid CoA transferase deficiency 01/2020
1	Pyruvate Dehydrogenase Complex Deficiency Disease 01/2020
1	Tics (Tic) 01/2020
1	Tourette Syndrome (Tourette's Syndrome) 01/2020
1	Ketosis 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Starvation 01/2019
1	Metabolic Diseases (Metabolic Disease) 10/2018
1	Overnutrition 01/2018
1	Cardiomegaly (Heart Hypertrophy) 03/2016
1	Heart Failure 03/2016
1	Fibrosis (Cirrhosis) 03/2016
1	Diabetes Complications 01/2015
1	Cardiomyopathies (Cardiomyopathy) 08/2014
1	Atherosclerosis 01/2013
1	Hyperinsulinism (Hyperinsulinemia) 09/2012
1	Bursitis (Adhesive Capsulitis) 09/2011
1	Hypertrophy 01/2011
1	Overweight 05/2009
1	Coma (Comas) 12/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2006

Drug/Important Bio-Agent (IBA)

23	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2006
9	Insulin (Novolin)FDA Link 11/2022 - 12/2006
8	Glucagon (Glukagon)FDA Link 01/2023 - 06/2015
6	Peptides (Polypeptides)IBA 01/2023 - 06/2013
6	IncretinsIBA 01/2023 - 06/2013
6	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2013
5	gastric inhibitory polypeptide receptorIBA 01/2022 - 01/2012
4	CarbohydratesIBA 01/2023 - 12/2006
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 06/2013
4	Hormones (Hormone)IBA 01/2021 - 06/2013
3	tirzepatideIBA 01/2023 - 01/2020
3	Glucagon Receptors (Glucagon Receptor)IBA 11/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2009
3	LipidsIBA 01/2020 - 01/2013
3	Streptozocin (Streptozotocin)FDA Link 11/2015 - 03/2007
3	GlucocorticoidsIBA 01/2012 - 05/2006
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2023 - 01/2023
2	fibroblast growth factor 21IBA 01/2023 - 01/2023
2	Liraglutide FDA Link 01/2023 - 01/2023
2	SugarsIBA 01/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2020
2	Leucine (L-Leucine)FDA Link 10/2020 - 04/2017
2	EnzymesIBA 01/2020 - 10/2017
2	Messenger RNA (mRNA)IBA 10/2019 - 03/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016 - 08/2014
1	POEGMAIBA 01/2023
1	PolymersIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	semaglutideIBA 12/2022
1	Neutralizing AntibodiesIBA 12/2022
1	tesaglitazarIBA 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	AcidsIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Tricarboxylic AcidsIBA 01/2021
1	Pimozide (Orap)FDA Link 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	KetonesIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	CitrullineIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 10/2019
1	GhrelinIBA 01/2019
1	CytokinesIBA 01/2019
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Sirtuin 3IBA 01/2018
1	AdipokinesIBA 01/2017
1	MK0626IBA 03/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2016
1	Peptide Receptors (Peptide Receptor)IBA 01/2015
1	Apolipoproteins E (ApoE)IBA 01/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	taspoglutideIBA 01/2013
1	Drinking WaterIBA 01/2013
1	CorticosteroneIBA 09/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2011
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 05/2006

Therapy/Procedure

7	Therapeutics 01/2023 - 12/2006
2	Injections 01/2023 - 09/2011
1	Glycemic Control 01/2015